Redefining Stroke Recovery Through Precision Neurostimulation

NeuroHealix is pioneering transformative neurotreatment solutions designed to address one of the most pressing challenges in modern healthcare: long-term stroke disability. With nearly 800,000 Americans affected annually and a global economic burden exceeding $34 billion, stroke remains the leading cause of serious adult disability, and yet, there is a critical absence of FDA-approved therapies targeting the sub-acute and chronic phases of recovery.

Our proprietary neurostimulation technology is engineered to precisely target the motor and sensory deficits that hinder rehabilitation. By leveraging state-of-the-art stimulation techniques and evidence-based design, our approach is built to restore motor function, accelerate neuroplasticity, and dramatically improve quality of life for stroke survivors.

At the intersection of advanced neuroscience and breakthrough medical device engineering, NeuroHealix is redefining what's possible in neurorehabilitation, delivering smarter, safer, and more effective solutions that aim to close the therapeutic gap and reduce the long-term burden of stroke.

We welcome investors, clinical partners, and innovators to join us in driving the future of neurorecovery.